NeoGenomics (NEO) Soars 7.2%: Is Further Upside Left in the Stock?

NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.